The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Small Dense Low‐Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Open accessAbstract
Low‐density lipoprotein (LDL) plays a key role in the development and progression of atherosclerosis and cardiovascular disease. LDL consists of several subclasses of particles with different sizes and densities, including large buoyant (lb) and intermediate and small dense (sd) LDLs. It has been well documented that sdLDL has a greater atherogenic potential than that of other LDL subfractions and that sdLDL cholesterol (sdLDL‐C) proportion is a better marker for prediction of cardiovascular disease than that of total LDL‐C. Circulating sdLDL readily undergoes multiple atherogenic modifications in blood plasma, such as desialylation, glycation, and oxidation, that further increase its atherogenicity. Modified sdLDL is a potent inductor of inflammatory processes associated with cardiovascular disease. Several laboratory methods have been developed for separation of LDL subclasses, and the results obtained by different methods can not be directly compared in most cases. Recently, the development of homogeneous assays facilitated the LDL subfraction analysis making possible large clinical studies evaluating the significance of sdLDL in the development of cardiovascular disease. Further studies are needed to establish guidelines for sdLDL evaluation and correction in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“[1] Prospective Studies Collaboration, S.”
BackgroundLow-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 646
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
Hoogeveen, R. C., Gaubatz, J. W., Sun, W., Dodge, R. C., Crosby, J. R., Jiang, J., Couper, D., Virani, S. S., Kathiresan, S., Boerwinkle, E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303284 · Cited by 507
Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494 · cited 1×
“The specific role of sdLDL, the pathogenesis of atherosclerosis, and other diseases was the subject of numerous studies [17, 81].”
BackgroundOxidized Low-Density Lipoprotein and Atherosclerosis
Steinberg, D., & Witztum, J. L. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179697 · Cited by 460
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Mills, E. J., Rachlis, B., Wu, P., Devereaux, P. J., Arora, P., & Perri, D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.039 · Cited by 423
Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420
Presence of a modified low density lipoprotein in humans.
Avogaro, P., Bon, G. B., & Cazzolato, G. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.79 · Cited by 378
ULTRACENTRIFUGAL STUDIES OF LIPOPROTEINS OF HUMAN SERUM
Gofman, J. W., Lindgren, F. T., & Elliott, H. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51290-x · Cited by 291
Lipoprotein subfractions and cardiovascular disease risk
Krauss, R. M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b7756 · Cited by 272
Hoefner, D. M., Hodel, S. D., O’Brien, J. F., Branum, E. L., Sun, D., Meissner, I., & McConnell, J. P. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.266 · Cited by 266
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin, M. A., Brunzell, J. D., Fitch, W. L., & Krauss, R. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.520 · Cited by 262
Low-density lipoprotein size and cardiovascular risk assessment
Rizzo, M., & Berneis, K. (2006) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hci154 · Cited by 260
Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 238
Griffin, B. A., Caslake, M. J., Yip, B., Tait, G. W., Packard, C. J., & Shepherd, J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90131-2 · Cited by 231
Okazaki, M., Usui, S., Ishigami, M., Sakai, N., Nakamura, T., Matsuzawa, Y., & Yamashita, S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000155017.60171.88 · Cited by 228
Direct Determination of Lipoprotein Particle Sizes and Concentrations by Ion Mobility Analysis
Caulfield, M. P., Li, S., Lee, G., Blanche, P. J., Salameh, W. A., Benner, W. H., Reitz, R. E., & Krauss, R. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.100586 · Cited by 227
Zheng, C., Khoo, C., Furtado, J., & Sacks, F. M. (2010) · Circulation · doi:10.1161/circulationaha.109.875807 · Cited by 223
Small dense LDL: An emerging risk factor for cardiovascular disease
Hirayama, S., & Miida, T. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.09.010 · Cited by 204
Toledo, F. G. S., Sniderman, A. D., & Kelley, D. E. (2006) · Diabetes Care · doi:10.2337/dc06-0455 · Cited by 196
A novel and simple method for quantification of small, dense LDL
Hirano, T., Ito, Y., Saegusa, H., & Yoshino, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d300007-jlr200 · Cited by 192
Tribble, D. L., Rizzo, M., Chait, A., Lewis, D. M., Blanche, P. J., & Krauss, R. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00700-2 · Cited by 185
Lipoprotein atherogenicity: an overview of current mechanisms
Griffin, B. A. (1999) · Proceedings of the Nutrition Society · doi:10.1079/pns19990022 · Cited by 182
Tsai, M. Y., Steffen, B. T., Guan, W., McClelland, R. L., Warnick, R., McConnell, J., Hoefner, D. M., & Remaley, A. T. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302401 · Cited by 182
Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol
Ito, Y., Fujimura, M., Ohta, M., & Hirano, T. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.149559 · Cited by 181
Small Dense LDL Cholesterol and Coronary Heart Disease: Results from the Framingham Offspring Study
Ai, M., Otokozawa, S., Asztalos, B. F., Ito, Y., Nakajima, K., White, C. C., Cupples, L. A., Wilson, P. W., & Schaefer, E. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.137489 · Cited by 180
Fenofibrate: A Review of its Use in Dyslipidaemia
McKeage, K., & Keating, G. M. (2011) · Drugs · doi:10.2165/11208090-000000000-00000 · Cited by 175
The role of small, dense low density lipoprotein (LDL): a new look
Packard, C., Caslake, M., & Shepherd, J. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00107-2 · Cited by 171
Musunuru, K., Orho-Melander, M., Caulfield, M. P., Li, S., Salameh, W. A., Reitz, R. E., Berglund, G., Hedblad, B., Engström, G., Williams, P. T., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.190405 · Cited by 168
Hypertriglyceridemia and cardiovascular risk reduction
Jacobson, T. A., Miller, M. J., & Schaefer, E. J. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.002 · Cited by 164
Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.
Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-7-200904070-00007 · Cited by 163
Nikolic, D., Katsiki, N., Montalto, G., Isenovic, E., Mikhailidis, D., & Rizzo, M. (2013) · Nutrients · doi:10.3390/nu5030928 · Cited by 159
The composition and metabolism of large and small LDL
Diffenderfer, M. R., & Schaefer, E. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000067 · Cited by 159
Intrahepatic Fat Accumulation and Alterations in Lipoprotein Composition in Obese Adolescents
Cali, A. M. G., Zern, T. L., Taksali, S. E., de Oliveira, A. M., Dufour, S., Otvos, J. D., & Caprio, S. (2007) · Diabetes Care · doi:10.2337/dc07-1088 · Cited by 154
Arai, H., Kokubo, Y., Watanabe, M., Sawamura, T., Ito, Y., Minagawa, A., Okamura, T., & Miyamato, Y. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14936 · Cited by 146
Afilalo, J., Majdan, A. A., & Eisenberg, M. J. (2007) · Heart · doi:10.1136/hrt.2006.112508 · Cited by 144
Hirano, T., Ito, Y., Koba, S., Toyoda, M., Ikejiri, A., Saegusa, H., Yamazaki, J., & Yoshino, G. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000117179.92263.08 · Cited by 130
Packard, C. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236367.42755.c1 · Cited by 127
Orekhov, A. N., Tertov, V. V., & Mukhin, D. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90211-k · Cited by 120
Self-citationBelle, M. L., & Krauss, R. M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42342-9 · Cited by 117
Morgan, L., Griffin, B., Millward, D., DeLooy, A., Fox, K., Baic, S., Bonham, M., Wallace, J., MacDonald, I., Taylor, M., et al. (2009) · Public Health Nutrition · doi:10.1017/s1368980008003236 · Cited by 115 · cited 1×
“In patients with obesity, sdLDL levels can be corrected by antiobesity medications, such as orlistat and caloric restriction and changes in lifestyle [102, 103].”
BackgroundElectronegative low-density lipoprotein: Origin and impact on health and disease
Mello, A. P. D. Q., da Silva, I. T., Abdalla, D. S. P., & Damasceno, N. R. T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.028 · Cited by 115
Rizzo, M., Pernice, V., Frasheri, A., Lorenzo, G. D., Rini, G. B., Spinas, G. A., & Berneis, K. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03407.x · Cited by 107
Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104
Ayyobi, A. F., McGladdery, S. H., McNeely, M. J., Austin, M. A., Motulsky, A. G., & Brunzell, J. D. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077220.44620.9b · Cited by 103
Ensign, W. Y., Hill, N. S., & Heward, C. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059949 · Cited by 103
Magkos, F., Mohammed, B. S., & Mittendorfer, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.164 · Cited by 103
Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects
Sánchez‐Quesada, J. L., Benı́tez, S., Otal, C., Franco, M., Blanco‐Vaca, F., & Ordóñez‐Llanos, J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30111-5 · Cited by 101
Krauss, R. M., Wojnooski, K., Orr, J., Geaney, J. C., Pinto, C. A., Liu, Y., Wagner, J. A., Luk, J. A. M., Johnson‐Levonas, A. O., Anderson, M. S., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018010 · Cited by 99
Analytical capillary isotachophoresis of human serum lipoproteins
Schmitz, G., Möllers, C., & Richter, V. (1997) · Electrophoresis · doi:10.1002/elps.1150181015 · Cited by 97
Berneis, K. K., Jeanneret, C., Muser, J., Felix, B., & Miserez, A. R. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.017 · Cited by 92
Susceptibility of LDL and its subfractions to glycation
Soran, H., & Durrington, P. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328348a43f · Cited by 91
Lipoprotein-associated phospholipase A2 as a target of therapy
Macphee, C. H., Nelson, J. J., & Zalewski, A. A. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174155.61307.5f · Cited by 89
Interrelationships among subgroups of serum lipoproteins in normal human subjects
Krauss, R. M., Lindgren, F. T., & Ray, R. M. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90385-x · Cited by 86
Gerber, P. A., Thalhammer, C., Schmied, C. M., Spring, S., Amann-Vesti, B. R., Spinas, G. A., & Berneis, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072763 · Cited by 77
Goldberg, R., Temprosa, M., Otvos, J., Brunzell, J., Marcovina, S., Mather, K., Arakaki, R., Watson, K., Horton, E., & Barrett-Connor, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1452 · Cited by 74
Brunzell, J. D., Zambon, A., & Deeb, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.008 · Cited by 72
The Clinical Relevance of Low-Density-Lipoproteins Size Modulation by Statins
Rizzo, M., & Berneis, K. K. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-8283-x · Cited by 71
Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women.
Williams, P., VRANIZAN, K. M., & Krauss, R. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41440-3 · Cited by 70
Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia
Austin, M. A., Horowitz, H., Wijsman, E. M., Krauss, R. M., & Brunzell, J. D. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90011-5 · Cited by 69
Witte, D. R., Taskinen, M., Perttunen-Nio, H., van Tol, A., Livingstone, S. J., & Colhoun, H. M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300395-jlr200 · Cited by 67
Sánchez‐Quesada, J. L., Pérez, A., Caixàs, A., Rigla, M., Payés, A., Benı́tez, S., & Ordóñez‐Llanos, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7692 · Cited by 66
Krauss, R. M., Williams, P. T., Lindgren, F. T., & Wood, P. D. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.2.155 · Cited by 65
Comparability of methods for LDL subfraction determination: A systematic review
Chung, M., Lichtenstein, A. H., Ip, S., Lau, J., & Balk, E. M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.011 · Cited by 65
Nakou, E. S., Filippatos, T. D., Georgoula, M., Kiortsis, D. N., Tselepis, A. D., Mikhailidis, D. P., & Elisaf, M. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802177150 · Cited by 65
Ohmura, H., Mokuno, H., Sawano, M., Hatsumi, C., Mitsugi, Y., Watanabe, Y., Daida, H., & Yamaguchi, H. (2002) · Metabolism · doi:10.1053/meta.2002.34695 · Cited by 61
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease
Jaakkola, O., Solakivi, T., Tertov, V. V., Orekhov, A. N., Miettinen, T. A., & Nikkari, T. (1993) · Coronary Artery Disease · doi:10.1097/00019501-199304000-00010 · Cited by 58
Self-citationThe metabolic basis of atherogenic dyslipidemia
Vinik, A. I. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80065-1 · Cited by 58
Rapid Separation of LDL Subclasses by Iodixanol Gradient Ultracentrifugation
Davies, I. G., Graham, J. M., & Griffin, B. A. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023366 · Cited by 57
Serum small-dense LDL abnormalities in chronic renal disease patients
Chu, M., Wang, A. Y.-M., Chan, I. H.-S., Chui, S. H., & Lam, C. W. K. (2012) · British Journal of Biomedical Science · doi:10.1080/09674845.2012.12069133 · Cited by 54
Tertov, V. V., Bittolo-Bon, G., Sobenin, I. A., Cazzolato, G., Orekhov, A. N., & Avogaro, P. (1995) · Experimental and Molecular Pathology · doi:10.1006/exmp.1995.1018 · Cited by 54
Self-citationLipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects
Schmitz, G., & Orsó, E. (2015) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-015-0074-0 · Cited by 52
Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia
Pirillo, A., & Catapano, A. L. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.040 · Cited by 50
Shen, H., Xu, L., Lu, J., Hao, T., Ma, C., Yang, H., Lu, Z., Gu, Y., Zhu, T.-H., & Shen, G. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0143-x · Cited by 45
Chappey, B., Myara, I., Benoit, M., Mazière, C., Mazière, J., & MOATTI, N. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00172-7 · Cited by 41
Yee, M. S., Pavitt, D. V., Tan, T., Venkatesan, S., Godsland, I. F., Richmond, W., & Johnston, D. G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d700044-jlr200 · Cited by 39
Measurement of lipoprotein particle sizes using dynamic light scattering
Sakurai, T., Trirongjitmoah, S., Nishibata, Y., Namita, T., Tsuji, M., Hui, S., Jin, S., Shimizu, K., & Chiba, H. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010100 · Cited by 38
Albers, J. J., Kennedy, H., & Marcovina, S. M. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.003 · Cited by 37
Superko, H. R., Berneis, K. K., Williams, P. T., Rizzo, M., & Wood, P. D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.069 · Cited by 35
Satoh, N., Wada, H., Ono, K., Yamakage, H., Yamada, K., Nakano, T., Hattori, M., Shimatsu, A., Kuzuya, H., & Hasegawa, K. (2008) · Circulation Journal · doi:10.1253/circj.72.932 · Cited by 33
Fukushima, Y., Hirayama, S., Ueno, T., Dohi, T., Miyazaki, T., Ohmura, H., Mokuno, H., Miyauchi, K., Miida, T., & Daida, H. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.021 · Cited by 33
Florentin, M., Tselepis, A. D., Elisaf, M., Rizos, C. V., Mikhailidis, D. P., & Liberopoulos, E. N. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110793563825 · Cited by 30
Tertov, V. V., Sobenin, I. A., & Orekhov, A. N. (1996) · Free Radical Research · doi:10.3109/10715769609149054 · Cited by 29
Self-citationIn vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
Geiss, H. C., Bremer, S., Barrett, P. H. R., Otto, C., & Parhofer, K. G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300523-jlr200 · Cited by 27
Bañuls, C., Bellod, L., Jover, A., Martínez-Triguero, M. L., Víctor, V. M., Rocha, M., & Hernández‐Mijares, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.09.047 · Cited by 26
Hasegawa, G., Kajiyama, S., Tanaka, T., Imai, S., Kozai, H., Fujinami, A., Ohta, M., Obayashi, H., Park, H., Nakano, K., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.01.005 · Cited by 21
Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
Gouni‐Berthold, I., Mikhailidis, D. P., & Rizzo, M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.720974 · Cited by 15
Jacomella, V., Gerber, P. A., Mosimann, K., Husmann, M. J. W., Thalhammer, C., Wilkinson, I. B., Berneis, K. K., & Amann-Vesti, B. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108813 · Cited by 10
Cited by
Poznyak, A., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051835 · Cited by 1,163
Self-citationAntioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Sulaiman Rahman, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,149
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 554
Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
Poznyak, A. V., Nikiforov, N. G., Markin, A. M., Kashirskikh, D. A., Myasoedova, V. A., Gerasimova, E. V., & Orekhov, A. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.613780 · Cited by 370
Self-citation
Metadata
- Authors
- Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2017-01
- Volume
- 2017
- Issue
- 1
- Pages
- 1273042-1273042
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2613713616
- Cited by
- 457
- References
- 99
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.